All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2006-001200-36 | A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin) versus verteporfin photodynamic therapy (PDT) in patients with neovascular age-related macular degeneratio... | not-yet-due | |
Ongoing | 2007-005462-12 | A prospective, randomized, masked and controlled trial of intravitreal ranibizumab (LucentisĀ®) combined with transpupillary thermotherapy (TTT) in patients with neovascular age-related macular degener... | not-yet-due | |
Ongoing | 2008-006265-93 | A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (AvastinĀ®) for central retinal vein occlusion (CRVO). | not-yet-due | |
Ongoing | 2011-003297-81 | A prospective, randomized study on intravitreal Ozurdex for preventing recurrent vitreous hemorrhage following pars plana vitrectomy for proliferative diabetic retinopathy | not-yet-due |